Parmax Pharma informs about details of loss of certificate

17 Jun 2023 Evaluate
Parmax Pharma has informed about intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further, pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022 a Letter of Confirmation will be issued to the securities holder/claimant upon completion of necessary procedures regarding duplicate Share Certificate.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

41.30 -0.11 (-0.27%)
28-Mar-2025 11:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...